Increasing SARS-CoV-2 (COVID-19) testing capacity at the Nebraska Veterinary Diagnostic Center

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 1U18FD008035-01

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2023
    2024
  • Known Financial Commitments (USD)

    $87,793
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    PROFESSOR AND DIRECTOR John Loy
  • Research Location

    United States of America
  • Lead Research Institution

    UNIVERSITY OF NEBRASKA LINCOLN
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    Data Management and Data Sharing

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Project Summary/Abstract The Nebraska Veterinary Diagnostic Center (NVDC) is a full-service veterinary diagnostic laboratory, is fully accredited by the American Association of Veterinary Laboratory Diagnosticians, is a member of FDA-CVM Vet-LIRN network, is a National Animal Health Laboratory Network (NAHLN) Level 1 laboratory, and is a certificated laboratory for National Poultry Improvement Plan testing. The laboratory processes over 300,000 specimens annually from a variety of species including livestock, companion animals, poultry, wildlife, and zoo animals. As part of a collaborative effort to enhance surveillance for SARS-CoV-2 in animals, more than 3,600 animals diverse animal species were tested in 2022-2023. To increase the diagnostics testing capacity and capabilities for SARS-CoV-2 in animals, the NVDC is seeking funds to purchase a digital PCR system. This equipment will enable the NVDC to enhance SARS-CoV-2 diagnostic testing by allowing extremely sensitive detection of SARS-CoV-2 in animal specimens. Additionally, the digital PCR approaches allows for quantification of SAR- CoV-2 genomes in clinical samples, which will help inform clinicians and One Health partners in assessing virus levels and transmission in animals.